Dislocated Intraocular Lens Extraction and Iris-Claw Lens Implantation in Vitrectomized and Non-vitrectomized Eyes

• Published in: Turk oftalmoloji gazetesi Vol. 49; no. 5; pp. 277 - 282
• Main Authors: Ersöz, M. Giray, Hocaoğlu, Mümin, Sayman Muslubaş, Işıl Bahar, Arf, Serra, Karaçorlu, Murat
• Format: Journal Article
• Language: English
• Published: Turkey Galenos Yayinevi Tic. Ltd 01.10.2019; Türk Oftalmoloji Derneği; Galenos Publishing; Galenos Yayinevi
• Subjects: aphakia; Artificial Lens Implant Migration - diagnosis; Artificial Lens Implant Migration - surgery; Device Removal - methods; Endothelium; Female; Follow-Up Studies; Glaucoma; Humans; Hyphema; intraocular lens dislocation; Intraocular lenses; Iris - surgery; iris-claw lens; Lenses, Intraocular; Male; Middle Aged; Original; Prosthesis Design; Reoperation; Retrospective Studies; secondary lens implantation; Time Factors; Tıp; Tropicamide; Visual Acuity; Vitrectomy; İstanbul; Türkiye; Aphakia; intraocular lens dislocation; secondary lens implantation; vitrectomy; iris-claw lens
• ISSN: 1300-0659; 2149-8695; 2149-8709; 2147-2661
• DOI: 10.4274/tjo.galenos.2019.79735

To compare the outcomes and complications of dislocated intraocular lens (IOL) extraction and secondary iris-claw IOL (ICIOL) implantation in vitrectomized and non-vitrectomized eyes. This retrospective study included 19 vitrectomized eyes and 11 non-vitrectomized eyes that underwent dislocated IOL extraction and secondary anterior chamber ICIOL implantation between June 2014 and September 2017 and had at least one year of follow-up. There were no significant differences between the groups in terms of demographic data, operative time, baseline anatomic and functional measurements, or postoperative changes in these measurements (all p>0.05). Postoperative best corrected visual acuity was significantly higher than preoperative values in both groups (both p<0.05). Complication rates did not differ between the groups (all p>0.05). In both groups, endothelial cell density was significantly lower at postoperative 1 year compared to preoperative measurements. There was no significant difference between groups regarding endothelial cell loss (p=0.49). One vitrectomized eye had corneal decompensation. Other complications included hyphema, transient increase of intraocular pressure, secondary glaucoma, pupillary irregularity, and dislocation of ICIOL. Mean operative time was 26.4±5.9 minutes. Dislocated IOL extraction and secondary anterior chamber ICIOL implantation is a safe treatment option in both vitrectomized and non-vitrectomized eyes.